- What is Tisch MSRCNY?
- Our Research
- Stem Cell Trial
- Get Involved
We Need You Now More Than Ever.
Phase II Stem Cell Trial Is A Reality.
2016 has been a remarkable year in our journey to create a Future Without MS. We had unprecedented success in the FDA approved Phase I Stem Cell clinical trial to repair damage caused by MS. The positive results have resulted in FDA and IRB approvals to commence a Phase II trial. We are proud to say this is the first such study in the US to reach this stage.
Construction of a state-of-the-art $4 million Institute for Regenerative Cell Therapy begins immediately, thanks to the generosity of Gaye & James Pigott, Town Fair Tire Foundation, and Nancy & Alan Schwartz. Located on the 3rd floor of our Center, the state-of-the-art laboratory will house the adult stem cell manufacturing facility and infrastructure and have adjoining clinical treatment rooms. This planned expansion will enable the Tisch MS Research Center to move forward with our Phase II trial and beyond.
The stem cell lab will be operational in winter of 2018. And then the hard work begins. Thousands of MS patients around the world wake up hopeful every day that this trial will lead to a reversal of disability. Please join us in supporting this hope and mission.
Our staff is dedicated to finding the cause of and a cure for MS. We are poised to begin work on a potentially enormous scientific breakthrough. Your support of this trial is critical for its’ success.
Together, we have come so far. And we are so close to possibly repairing the damage caused by MS. Now more than ever before, we are counting on you to support our research. Please, Click Here To Donate Now.
On behalf of the entire Tisch MSRCNY team and the patients who benefit from our work, I thank you.
Saud A. Sadiq, MD, FAAN
Director and Chief Research Scientist